DEROSA, LISA Statistiche
DEROSA, LISA
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680â7
2018-01-01 Del Re, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients
2017-01-01 DEL RE, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide
2017-01-01 DEL RE, Marzia; Fogli, Stefano; Derosa, Lisa; Massari, Francesco; De Souza, Paul; Crucitta, Stefania; Bracarda, Sergio; Santini, Daniele; Danesi, Romano
[18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: Preliminary results
2016-01-01 Pasqualetti, Francesco; Panichi, Marco; Sainato, Aldo; Matteucci, Fabrizio; Galli, Luca; Cocuzza, Paola; Ferrazza, Patrizia; Coraggio, Gabriele; Pasqualetti, Giuseppe; Derosa, Lisa; Sollini, Martina; Mannelli, Lorenzo; Ortori, Simona; Monzani, Fabio; Ricci, Sergio; Greco, Carlo; Fabrini, Maria Grazia; Erba, PAOLA ANNA
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients
2016-01-01 DI DESIDERO, Teresa; Derosa, Lisa; Galli, Luca; Orlandi, Paola; Fontana, Andrea; Fioravanti, Anna; Marconcini, Riccardo; Giorgi, Mario; Campi, Beatrice; Saba, Alessandro; Lucchesi, Sara; Felipetto, Renato; Danesi, Romano; Francia, Giulio; Allegrini, Giacomo; Falcone, Alfredo; Bocci, Guido
Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC)
2015-01-01 Farnesi, A.; Mazzarri, S.; Boni, G.; Galli, L.; Cianci, C.; Borso', Elisa; Marconcini, R.; Biasco, Elisa; Derosa, Lisa; Sbrana, A.; Antonuzzo, A.; Ricci, S.; Volterrai, D.; Falcone, Alfredo
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients
2015-01-01 Solini, Anna; Simeon, Vittorio; Derosa, Lisa; Orlandi, Paola; Rossi, Chiara; Fontana, Andrea; Galli, Luca; DI DESIDERO, Teresa; Fioravanti, Anna; Lucchesi, Sara; Coltelli, Luigi; Ginocchi, Laura; Allegrini, Giacomo; Danesi, Romano; Falcone, Alfredo; Bocci, Guido
metastatic well or moderately differentiated Neuroendocrine tumors (WDNET) treated with sequence of different Somatostatin Analogs (SSA) - Lanreotide LAR (La), Octreotide LAR (Oc): a single center experience
2015-01-01 Marconcini, R.; Ricci, S.; Galli, L.; Antonuzzo, A.; Farnesi, A.; Derosa, Lisa; Biasco, Elisa; Falcone, Alfredo
New Prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC).
2015-01-01 Derosa, Lisa; Guida, A.; Albiges, L.; Massard, C.; Loriot, Y.; Biasco, Elisa; Farnesi, A.; Marconcini, R.; Galli, L.; Falcone, Alfredo; Fizazi, K.; Escudier, B.
predictive factors of efficacy of somatostatine analogs (SSA) in gastroenteropancreatic neuroendocrine tumors (GEP-NET)
2015-01-01 Ricci, S.; Marconcini, R.; Galli, L.; Antonuzzo, A.; Farnesi, A.; Derosa, Lisa; Biasco, Elisa; Falcone, Alfredo
Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: Efficacy of octreotide and tamoxifen
2015-01-01 Biasco, Elisa; Antonuzzo, Andrea; Galli, Luca; Baldi, Giacomo Giulio; Derosa, Lisa; Marconcini, Riccardo; Farnesi, Azzurra; Ricci, Sergio; Falcone, Alfredo
EARLY AND COMPLETE CLINICAL RESPONSE TO SUNITINIB IN A PATIENT WITH METASTATIC RENAL CANCER
2014-01-01 Biasco, E; Farnesi, A; Aringhieri, G; Derosa, L; Marconcini, R; Galli, L; Antonuzzo, A; Cianci, C; Ricci, S; Caramella, D; Falcone, A
OCTREOTIDE LAR SUITABLE TREATMENT FOR G1-G2 THORACIC NEUROENDOCRINE TUMORS (T-NET): SINGLE CENTER EXPERIENCE
2014-01-01 Marconcini, Riccardo; Petrini, Iacopo; Galli, Luca; Vasile, Enrico; Antonuzzo, Andrea; Farnesi, Azzurra; Derosa, Lisa; Bracco, Elena; Viglialoro, R.; Falcone, Alfredo; Ricci, Sergio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680â7 | 1-gen-2018 | Del Re, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano | |
| The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients | 1-gen-2017 | DEL RE, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano | |
| The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide | 1-gen-2017 | DEL RE, Marzia; Fogli, Stefano; Derosa, Lisa; Massari, Francesco; De Souza, Paul; Crucitta, Stefania; Bracarda, Sergio; Santini, Daniele; Danesi, Romano | |
| [18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: Preliminary results | 1-gen-2016 | Pasqualetti, Francesco; Panichi, Marco; Sainato, Aldo; Matteucci, Fabrizio; Galli, Luca; Cocuzza, Paola; Ferrazza, Patrizia; Coraggio, Gabriele; Pasqualetti, Giuseppe; Derosa, Lisa; Sollini, Martina; Mannelli, Lorenzo; Ortori, Simona; Monzani, Fabio; Ricci, Sergio; Greco, Carlo; Fabrini, Maria Grazia; Erba, PAOLA ANNA | |
| Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients | 1-gen-2016 | DI DESIDERO, Teresa; Derosa, Lisa; Galli, Luca; Orlandi, Paola; Fontana, Andrea; Fioravanti, Anna; Marconcini, Riccardo; Giorgi, Mario; Campi, Beatrice; Saba, Alessandro; Lucchesi, Sara; Felipetto, Renato; Danesi, Romano; Francia, Giulio; Allegrini, Giacomo; Falcone, Alfredo; Bocci, Guido | |
| Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC) | 1-gen-2015 | Farnesi, A.; Mazzarri, S.; Boni, G.; Galli, L.; Cianci, C.; Borso', Elisa; Marconcini, R.; Biasco, Elisa; Derosa, Lisa; Sbrana, A.; Antonuzzo, A.; Ricci, S.; Volterrai, D.; Falcone, Alfredo | |
| Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients | 1-gen-2015 | Solini, Anna; Simeon, Vittorio; Derosa, Lisa; Orlandi, Paola; Rossi, Chiara; Fontana, Andrea; Galli, Luca; DI DESIDERO, Teresa; Fioravanti, Anna; Lucchesi, Sara; Coltelli, Luigi; Ginocchi, Laura; Allegrini, Giacomo; Danesi, Romano; Falcone, Alfredo; Bocci, Guido | |
| metastatic well or moderately differentiated Neuroendocrine tumors (WDNET) treated with sequence of different Somatostatin Analogs (SSA) - Lanreotide LAR (La), Octreotide LAR (Oc): a single center experience | 1-gen-2015 | Marconcini, R.; Ricci, S.; Galli, L.; Antonuzzo, A.; Farnesi, A.; Derosa, Lisa; Biasco, Elisa; Falcone, Alfredo | |
| New Prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC). | 1-gen-2015 | Derosa, Lisa; Guida, A.; Albiges, L.; Massard, C.; Loriot, Y.; Biasco, Elisa; Farnesi, A.; Marconcini, R.; Galli, L.; Falcone, Alfredo; Fizazi, K.; Escudier, B. | |
| predictive factors of efficacy of somatostatine analogs (SSA) in gastroenteropancreatic neuroendocrine tumors (GEP-NET) | 1-gen-2015 | Ricci, S.; Marconcini, R.; Galli, L.; Antonuzzo, A.; Farnesi, A.; Derosa, Lisa; Biasco, Elisa; Falcone, Alfredo | |
| Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: Efficacy of octreotide and tamoxifen | 1-gen-2015 | Biasco, Elisa; Antonuzzo, Andrea; Galli, Luca; Baldi, Giacomo Giulio; Derosa, Lisa; Marconcini, Riccardo; Farnesi, Azzurra; Ricci, Sergio; Falcone, Alfredo | |
| EARLY AND COMPLETE CLINICAL RESPONSE TO SUNITINIB IN A PATIENT WITH METASTATIC RENAL CANCER | 1-gen-2014 | Biasco, E; Farnesi, A; Aringhieri, G; Derosa, L; Marconcini, R; Galli, L; Antonuzzo, A; Cianci, C; Ricci, S; Caramella, D; Falcone, A | |
| OCTREOTIDE LAR SUITABLE TREATMENT FOR G1-G2 THORACIC NEUROENDOCRINE TUMORS (T-NET): SINGLE CENTER EXPERIENCE | 1-gen-2014 | Marconcini, Riccardo; Petrini, Iacopo; Galli, Luca; Vasile, Enrico; Antonuzzo, Andrea; Farnesi, Azzurra; Derosa, Lisa; Bracco, Elena; Viglialoro, R.; Falcone, Alfredo; Ricci, Sergio |